Literature DB >> 29261231

The Study of Host Immune Responses Elicited by the Model Murine Hookworms Nippostrongylus brasiliensis and Heligmosomoides polygyrus.

T Bouchery1, B Volpe1, K Shah1, L Lebon1, K Filbey2, G LeGros2, N Harris1.   

Abstract

Hookworm infections (Necator americanus or Ancylostoma duodenale) represent a major neglected tropical disease, affecting approximately 700 million people worldwide, and can cause severe morbidity due to the need for these worms to feed on host blood. N. brasiliensis and H. polygrus, both rodent parasites, are the two most commonly employed laboratory models of experimental hookworm infection. Both parasites evoke type 2 immune responses, and their use has been instrumental in generating fundamental insight into the molecular mechanisms of type-2 immunity and for understanding how the immune response can control parasite numbers. Here we provide a complete set of methods by which to investigate the natural progression of infection and the host immunological responses in the lung and intestine of H. polygyrus- and N. brasiliensis-infected mice. Detailed information is included about the most important parasitological and immunological measurements to perform at each time point. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  AAM; H. polygyrus; ILC2s; N. brasiliensis; Th2; hookworms

Mesh:

Year:  2017        PMID: 29261231     DOI: 10.1002/cpmo.34

Source DB:  PubMed          Journal:  Curr Protoc Mouse Biol        ISSN: 2161-2617


  11 in total

Review 1.  Eosinophils and Macrophages within the Th2-Induced Granuloma: Balancing Killing and Healing in a Tight Space.

Authors:  Anupama Ariyaratne; Constance A M Finney
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

2.  Preparation of Nippostrongylus brasiliensis Larvae for the Study of Host Skin Response.

Authors:  Tiffany Bouchery; Gillian Coakley; Nicola L Harris
Journal:  Bio Protoc       Date:  2020-12-20

3.  Enteric helminth coinfection enhances host susceptibility to neurotropic flaviviruses via a tuft cell-IL-4 receptor signaling axis.

Authors:  Pritesh Desai; Hana Janova; James P White; Glennys V Reynoso; Heather D Hickman; Megan T Baldridge; Joseph F Urban; Thaddeus S Stappenbeck; Larissa B Thackray; Michael S Diamond
Journal:  Cell       Date:  2021-02-25       Impact factor: 66.850

4.  Interrogating the Small Intestine Tuft Cell-ILC2 Circuit Using In Vivo Manipulations.

Authors:  Claire E O'Leary; Xiaogang Feng; Victor S Cortez; Richard M Locksley; Christoph Schneider
Journal:  Curr Protoc       Date:  2021-03

Review 5.  ILC2s-Trailblazers in the Host Response Against Intestinal Helminths.

Authors:  Tiffany Bouchery; Graham Le Gros; Nicola Harris
Journal:  Front Immunol       Date:  2019-04-04       Impact factor: 7.561

6.  Tissue-specific pathways extrude activated ILC2s to disseminate type 2 immunity.

Authors:  Roberto R Ricardo-Gonzalez; Christoph Schneider; Chang Liao; Jinwoo Lee; Hong-Erh Liang; Richard M Locksley
Journal:  J Exp Med       Date:  2020-04-06       Impact factor: 14.307

Review 7.  CRISPR/Cas9 Mutagenesis and Expression of Dominant Mutant Transgenes as Functional Genomic Approaches in Parasitic Nematodes.

Authors:  James B Lok
Journal:  Front Genet       Date:  2019-07-16       Impact factor: 4.599

Review 8.  Immunomodulation and Immune Escape Strategies of Gastrointestinal Helminths and Schistosomes.

Authors:  Marie Wiedemann; David Voehringer
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

9.  Trichuris muris and comorbidities - within a mouse model context.

Authors:  Kelly S Hayes; Richard K Grencis
Journal:  Parasitology       Date:  2021-06-03       Impact factor: 3.234

10.  Basophils prime group 2 innate lymphoid cells for neuropeptide-mediated inhibition.

Authors:  Juan M Inclan-Rico; John J Ponessa; Nuriban Valero-Pacheco; Christina M Hernandez; Chandler B Sy; Alexander D Lemenze; Aimee M Beaulieu; Mark C Siracusa
Journal:  Nat Immunol       Date:  2020-08-17       Impact factor: 31.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.